why choose us

First received: December 06, 2023

Clinical Trial: Obsidio™ Conformable Embolic Registry

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Hypervascular Tumors

Study Type: OBSERVATIONAL


Official Title: A Prospective, Post-Approval, Open-Label, Multi-Center United States (US) Registry to Evaluate the Effectiveness and Safety of Obsidio in Clinical Practice

Brief Summary: OCCLUDE is a prospective, post-approval, open-label, single arm, multi-center US registry of patients who undergo embolization with Obsidio™ Conformable Embolic.The purpose of this Registry is to assess effectiveness and safety outcomes of subjects who undergo embolization with Obsidio.

Read more